PARP Inhibitors Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Olaparib
1.2.3 Talazoparib
1.3 Market by Application
1.3.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Ovarian Cancer
1.3.3 Breast Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Perspective (2017-2028)
2.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Growth Trends by Region
2.2.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Region (2017-2022)
2.2.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Region (2023-2028)
2.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Dynamics
2.3.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Trends
2.3.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Drivers
2.3.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Challenges
2.3.4 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Revenue
3.1.1 Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Revenue (2017-2022)
3.1.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Players (2017-2022)
3.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue
3.4 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Concentration Ratio
3.4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue in 2021
3.5 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players Head office and Area Served
3.6 Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Product Solution and Service
3.7 Date of Enter into PARP (Poly ADP-ribose Polymerase) Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PARP (Poly ADP-ribose Polymerase) Inhibitors Breakdown Data by Type
4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Type (2017-2022)
4.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Type (2023-2028)
5 PARP (Poly ADP-ribose Polymerase) Inhibitors Breakdown Data by Application
5.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Application (2017-2022)
5.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2017-2028)
6.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022)
6.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2017-2028)
7.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022)
7.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2017-2028)
8.2 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022)
8.3 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2017-2028)
9.2 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022)
9.3 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2017-2028)
10.2 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022)
10.3 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.1.4 AbbVie Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
11.1.5 AbbVie Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.2.4 Pfizer Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
11.2.5 Pfizer Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.3.4 AstraZeneca Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
11.3.5 AstraZeneca Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.4.4 GlaxoSmithKline Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Development
11.5 Clovis Oncology
11.5.1 Clovis Oncology Company Detail
11.5.2 Clovis Oncology Business Overview
11.5.3 Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.5.4 Clovis Oncology Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
11.5.5 Clovis Oncology Recent Development
11.6 Everest Pharmaceuticals
11.6.1 Everest Pharmaceuticals Company Detail
11.6.2 Everest Pharmaceuticals Business Overview
11.6.3 Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.6.4 Everest Pharmaceuticals Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
11.6.5 Everest Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Olaparib
Table 3. Key Players of Talazoparib
Table 4. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region (2017-2022)
Table 8. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region (2023-2028)
Table 10. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Trends
Table 11. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Drivers
Table 12. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Challenges
Table 13. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Restraints
Table 14. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Players (2017-2022)
Table 16. Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors as of 2021)
Table 17. Ranking of Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Product Solution and Service
Table 21. Date of Enter into PARP (Poly ADP-ribose Polymerase) Inhibitors Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2017-2022)
Table 25. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2023-2028)
Table 27. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Application (2017-2022)
Table 29. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Application (2023-2028)
Table 31. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028) & (US$ Million)
Table 41. AbbVie Company Detail
Table 42. AbbVie Business Overview
Table 43. AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 44. AbbVie Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)
Table 45. AbbVie Recent Development
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 49. Pfizer Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. AstraZeneca Company Detail
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 54. AstraZeneca Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)
Table 55. AstraZeneca Recent Development
Table 56. GlaxoSmithKline Company Detail
Table 57. GlaxoSmithKline Business Overview
Table 58. GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 59. GlaxoSmithKline Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)
Table 60. GlaxoSmithKline Recent Development
Table 61. Clovis Oncology Company Detail
Table 62. Clovis Oncology Business Overview
Table 63. Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 64. Clovis Oncology Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)
Table 65. Clovis Oncology Recent Development
Table 66. Everest Pharmaceuticals Company Detail
Table 67. Everest Pharmaceuticals Business Overview
Table 68. Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 69. Everest Pharmaceuticals Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)
Table 70. Everest Pharmaceuticals Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type: 2021 VS 2028
Figure 2. Olaparib Features
Figure 3. Talazoparib Features
Figure 4. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application in 2021 & 2028
Figure 5. Ovarian Cancer Case Studies
Figure 6. Breast Cancer Case Studies
Figure 7. Other Case Studies
Figure 8. PARP (Poly ADP-ribose Polymerase) Inhibitors Report Years Considered
Figure 9. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region: 2021 VS 2028
Figure 12. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Players in 2021
Figure 13. Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue in 2021
Figure 15. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Country (2017-2028)
Figure 17. United States PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Country (2017-2028)
Figure 21. Germany PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region (2017-2028)
Figure 29. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Country (2017-2028)
Figure 37. Mexico PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Country (2017-2028)
Figure 41. Turkey PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. AbbVie Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
Figure 44. Pfizer Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
Figure 45. AstraZeneca Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
Figure 46. GlaxoSmithKline Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
Figure 47. Clovis Oncology Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
Figure 48. Everest Pharmaceuticals Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed